Latest News

  • REGULATORY

    4 Dec 2025

    HHS Shift Reshapes Momentum and Strategy Across mRNA Sector

  • INNOVATION

    3 Dec 2025

    AI Tools Edge Into mRNA Design

  • PARTNERSHIPS

    2 Dec 2025

    A New mRNA Alliance Tests What Comes After COVID

  • INVESTMENT

    1 Dec 2025

    Can A Big Bet On mRNA Reset Biotech’s Pace?

The Push to Turn mRNA Into a Cancer Weapon

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

3D illustration of an mRNA lipid nanoparticle releasing RNA strands into surrounding molecules.

REGULATORY

20 Nov 2025

US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

Moderna, Replicate, and others accelerate mRNA advances as the US faces rising pressure to update its regulatory approach

Technicians working in an mRNA bioprocessing lab with stainless steel bioreactors.

PARTNERSHIPS

18 Nov 2025

New Alliance Aims to Steady the mRNA Supply Chain

Wacker Biotech and RNAV8 Bio join forces to streamline mRNA development and create a more predictable path to the clinic

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

Can mRNA Rewrite the Future of Rare Disease Care?

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

3D illustration of an mRNA strand, syringe, and virus particle symbolizing mRNA research.

INSIGHTS

10 Nov 2025

What BioNTech’s CureVac Deal Says About mRNA’s Future

BioNTech’s $1.25B CureVac deal pushes mRNA beyond vaccines toward cancer treatment

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

PARTNERSHIPS

20 Aug 2025

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

AbbVie's Capstan buy signals a bold leap into in-vivo mRNA therapies, reshaping the race for next-gen autoimmune treatments.

Early Cancer Trial Puts mRNA in the Spotlight

RESEARCH

14 Aug 2025

Early Cancer Trial Puts mRNA in the Spotlight

Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.